drugset / Trial / NCT00517868

Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis

NCT00517868

Phase 2 Terminated 28 enrolled Urigen
RandomizedCrossoverDouble-blindTreatment

Summary

A double-blind, placebo-controlled study to evaluate changes in pain, urgency and urinary frequency following administration of URG101 compared to placebo.

Timeline

Start
2007-08-28
Primary completion
2008-02-28
Completion
2008-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject URG101 Unknown Other

Indications